Spasticity, following the neurological disorder of cerebral palsy (CP), describes a
pathological condition, the central feature of which is involuntary and prolonged muscle …

Spasticity, following the neurological disorder of cerebral palsy (CP), describes a
pathological condition, the central feature of which is involuntary and prolonged muscle …

Background: Cerebral palsy (CP) is the most common cause of childhood disability globally.
Botulinum toxin A injections are widely used to manage limb spasticity in children with CP …

This review aims to determine the analgesic efficacy of botulinum toxin (BTX) for the
management of pain in children with cerebral palsy (CP). During July and August 2020, a …

Pain and quality of life are closely interrelated in children with cerebral palsy (CCP). Even
though 67% of CCP experience pain, it is overlooked and untreated. In this study, our …

Sixty-seven percent of children with cerebral palsy (CCP) experience pain. Pain is closely
interrelated to diminished quality of life. Despite this, pain is an overlooked and undertreated …

Objectives To investigate if chronic pain in children with cerebral palsy is undertreated with
the current pharmacological/non-pharmacological interventions using a pain management …

PURPOSE: To explore the existing literature on non-pharmacological and non-surgical pain
management in children and adolescents with cerebral palsy (CP). METHODS: Databases …

PURPOSE: A large prospective database from three Phase 3 studies allowed the study of
spasticity-related pain (SRP) in pediatric cerebral palsy (CP). METHODS: Baseline …

PURPOSE: This study aimed to explore the feasibility of using time-matched uniaxial
accelerometers for measuring movement in daily life in children with cerebral palsy (CP) …